GLG News by Corneal and Refractive Ophthalmic Surgeons (US)

This glaucoma drug efficacy crossover study shows that bimatoprost (Lumigan) from AGN lowers intraocular pressure better than latanoprost (Xalatan) from PFE in a special subset of glaucoma patients (exfoliative glaucoma).  The difference is only 1 mm Hg which may be statistically significant will...

Bayer and Regeneron are moving forward with their Phase 3 Trial called the VIEW involving VEGF Trap for the treatment for choroidal neovascularization in Age Related Macular Degeneration.  The implications are large for a billion dollar market that is currently dominated by Lucentis (DNA).

Bad news merger of AMO and B&L..

This uncontrolled pilot study in 12 eyes reports that that high density silicone oil was successful in the treatment of a complex retinal disease problem, a macular hole with a central retinal detachment in myopic patients.  Although this work is exciting for this particular condition, its applications...

Bausch & Lomb (BOL) is in a bidding war with a private equity firm (Warburg Pincus) and Advanced Medical Optics (EYE).  AMO's Bid is $10 higher (15% Premium) and appeals to be superior but there is unclear resistance which may lead to its denial.  The implications could significantly impact...

This small study involving 14 patients claims that monovision may help correct presbyopia in cataract patients.  This concept is nothing new as monovision through contact lens, refractive surgery (LASIK) or intraocular lenses (IOLs) has been around for years.  Monovision is only tolerated...

AMO's VISX has about 50% of the excimer laser business.  B&L has the number 2 spot with about 25% of the market share.  A take over by AMO could pose a monopoly in the laser market, that can hinder innovation. 

Custom lasers were unable to achieve monovision in the past since hey capture and treat the whole refractive error of the eye.  The ability to perform monovision in a custom platform will make easier for practices to offer more custom procedures to the 40+ patients, thus translating into higher...

This retrospective study affirms the previous thoughts about amblyopia in children.  Children with bilateral cataracts should have both cataracts removed as soon as possible to minimize the effects of amblopia and maintain normal visual development. The implications for the marketplace for cataract...

ALCON has real chance in expanding its laser refractive market share.  Getting rid of a less than optimal platform and replacing it with the Allegretto laser has excellent potential for ALCON.